Zynerba Pharmaceuticals Inc.

Rank 103
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
$0.5500
USD
-4.72%
Market cap
$12,758,905
Total volume
$276,491
Shares outstanding
23,198,010
Rank 103
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
Markets
Exchange | Symbol | Volume (24h) | Volume (%) | Price |
---|---|---|---|---|
|
ZYNE |
$276,491
|
100% |
$0.5500
|
Chart